Mirae Asset Global Investments
OCUL icon

Mirae Asset Global Investments’s Ocular Therapeutix OCUL Stock Holding History

Mirae Asset Global Investments’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.2K Sell
9,793
-1,562
-14% -$14.2K ﹤0.01% 1243
2026
Q1 		$96.2K Buy
11,355
+1,002
+10% +$9.55K ﹤0.01% 1192
2025
Q4 		$126K Buy
10,353
+3,626
+54% +$44K ﹤0.01% 1220
2025
Q3 		$78.6K Buy
6,727
+573
+9% +$6.85K ﹤0.01% 1263
2025
Q2 		$57.1K Buy
6,154
+893
+17% +$6.99K ﹤0.01% 1236
2025
Q1 		$39.9K Buy
5,261
+22
+0.4% +$169 ﹤0.01% 1277
2024
Q4 		$44.2K Sell
5,239
-400
-7% -$3.9K ﹤0.01% 1282
2024
Q3 		$48.9K Buy
5,639
+1,015
+22% +$8.37K ﹤0.01% 1308
2024
Q2 		$31.3K Sell
4,624
-48,832
-91% -$301K ﹤0.01% 1325
2024
Q1 		$284K Buy
+53,456
New +$379K ﹤0.01% 2125
2023
Q4 		– Sell
-52,049
Closed -$163K – 2578
2023
Q3 		$163K Buy
52,049
+112
+0.2% +$458 ﹤0.01% 2357
2023
Q2 		$268K Sell
51,937
-147
-0.3% -$874 ﹤0.01% 2230
2023
Q1 		$274K Buy
+52,084
New +$247K ﹤0.01% 2204
2022
Q4 		– Sell
-33,415
Closed -$139K – 2572
2022
Q3 		$139K Buy
33,415
+9,823
+42% +$49.5K ﹤0.01% 2439
2022
Q2 		$95K Buy
+23,592
New +$89.1K ﹤0.01% 2313

Other funds holding OCUL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Mirae Asset Global Investments's OCUL Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Ocular Therapeutix (OCUL) stake by 14% in Q2 2026, selling an estimated $14.2K and leaving 9,793 shares worth $96.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Mirae Asset Global Investments first reported a position in OCUL in Q2 2022 and has held it in 15 quarters since. The position peaked at $284K in Q1 2024. 92 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Mirae Asset Global Investments held 9,793 shares of Ocular Therapeutix worth $96.2K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,562 Ocular Therapeutix shares in Q2 2026, an estimated $14.2K.
  • Ocular Therapeutix made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1243 holding.
  • Mirae Asset Global Investments first reported a position in Ocular Therapeutix in Q2 2022 and has held it in 15 quarters since.
  • Mirae Asset Global Investments's Ocular Therapeutix position peaked at $284K in Q1 2024.
  • 92 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.